US Patent Issued to Glioblastoma Foundation on July 29 for "Processes for the preparation of furazanobenzimidazoles and crystalline forms thereof" (Swiss Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,424, issued on July 29, was assigned to Glioblastoma Foundation Inc. (Durham, N.C.).

"Processes for the preparation of furazanobenzimidazoles and crystalline forms thereof" was invented by Gregor Welti (Basel, Switzerland), Markus Heubes (Basel, Switzerland) and David Tagliaferri (Basel, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides processes for preparing a compound of formula I and pharmaceutically acceptable salts thereof,comprising deprotecting a compound of formula IIwherein each R3 independently represents a tertiary alkyl group, preferably wherein each R3 is tertiary butyl. The invention also provid...